Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-15

Clinical Trial Update: Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a new combination bronchodilator's effect on exercise in patients with moderate chronic obstructive pulmonary disease (GOLD stage II)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • New Combination Bronchodilator

Snippet

Sponsor: Queen's University | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2017-08-15